The global cell and gene therapy cold chain logistics market is predicted to reach a value of US$1,655 million by 2023, with expected growth until 2033. The market report analyzes various segments, including components, services, and modes of transport. Patient access programs play a significant role in ensuring therapy reaches those with rare or serious diseases, but the high cost of storage and transport can hinder growth. Stringent government regulations for importation are also identified as potential obstacles. The report offers analysis and insights for companies looking for expansion opportunities.